Supplementary Table 4 from Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth
收藏Figshare2025-08-01 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Supplementary_Table_4_from_Navitoclax_a_Bcl-2_xL_Inhibitor_and_YM155_a_Survivin_Inhibitor_in_Combination_with_Carboplatin_Effectively_Inhibit_Ovarian_Cancer_Tumor_Growth/29759629
下载链接
链接失效反馈官方服务：
资源简介：
72 h combinatorial drug screen
创建时间：
2025-08-01
